Your browser doesn't support javascript.
loading
Hemicrania continua responsive to botulinum toxin type a: a case report.
Khalil, Modar; Ahmed, Fayyaz.
Afiliación
  • Khalil M; Department of Neurology, Hull Royal Infirmary, Kingston-upon-Hull, UK.
Headache ; 53(5): 831-3, 2013 May.
Article en En | MEDLINE | ID: mdl-23534367
BACKGROUND: Hemicrania continua (HC) is a primary headache disorder with full response to indomethacin as one of its diagnostic criteria; however, indomethacin's side effects could limit its use in HC. CASE RESULT: We report a 33-year-old lady whose headache fulfilled the criteria for HC, but the patient developed gastric side effect to indomethacin and did not respond to other pharmacological treatments; however, injecting botulinum toxin type A has led to complete resolution of all of her symptoms. DISCUSSION: We hypothesize the mechanism by which botulinum toxin type A has led to our results through reviewing recent functional neuroimaging findings used to understand the pathophysiology of different primary headache disorders.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Toxinas Botulínicas Tipo A / Cefalea / Fármacos Neuromusculares Límite: Adult / Female / Humans Idioma: En Revista: Headache Año: 2013 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Toxinas Botulínicas Tipo A / Cefalea / Fármacos Neuromusculares Límite: Adult / Female / Humans Idioma: En Revista: Headache Año: 2013 Tipo del documento: Article